News Quantified

BCLI – brainstorm cell therapeutics inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights

10.8%

MISS

10.8%

BEAT

-8.0%

BEAT

Form 10-Q BRAINSTORM CELL THERAPEU For: Sep 30

Form 8-K BRAINSTORM CELL THERAPEU For: Nov 10

Form 8-K BRAINSTORM CELL THERAPEU For: Oct 31

Form 25-NSE BRAINSTORM CELL THERAPEU Filed by: Nasdaq Stock Market LLC

Top News Gainers

2/14 Form 4 BRAINSTORM CELL THERAPEU For: Dec 12 Filed by: TAUB MALCOLM S 22.7%

2/11 BrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn® Regulatory Pathway for Approval in ALS 15.0%

3/6 BrainStorm Cell Therapeutics Raises $10.0 Million in Common Stock Sale at $8.00 Per Share 13.2%

4/3 Form 8-K BRAINSTORM CELL THERAPEU For: Apr 01 6.2%

4/29 BrainStorm-Cell Therapeutics to Announce First Quarter Financial Results and Provide a Corporate Update 5.6%

4/7 Form 3 BRAINSTORM CELL THERAPEU For: Mar 30 Filed by: Abbhi Sankesh 4.3%

11/20 BrainStorm Cell Therapeutics Announces Publication of NurOwn® ALS Phase 2 Randomized Clinical Trial Data in Neurology 4.0%

11/4 Interview With Chaim Lebovits, CEO Of Brainstorm Cell Therapeutics [Seeking Alpha] 3.5%

8/13 BrainStorm Announces Financial Results for the Second Quarter of 2019 and Provides a Corporate Update 3.3%

8/9 Form D BRAINSTORM CELL THERAPEU 3.1%

Top News Decliners

3/16 BrainStorm to Hold a Conference Call to Update Investors on Corporate Steps Taken to Address COVID-19 -24.4%

2/27 Fifth and Final Site Announced for BrainStorm’s Progressive Multiple Sclerosis Phase 2 Clinical Trial -14.4%

3/6 Form 4 BRAINSTORM CELL THERAPEU For: Mar 06 Filed by: Kern Ralph Dr. -14.3%

3/18 Form SC 13G BRAINSTORM CELL THERAPEU Filed by: Abbhi Investments, LLC -11.8%

2/13 Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -9.5%

8/2 Form 8-K BRAINSTORM CELL THERAPEU For: Aug 02 -5.4%

4/3 BrainStorm Cell +4% premarket on $1.5M grant [Seeking Alpha] -5.3%

11/18 Does Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Have A High Beta? [Yahoo! Finance News] -4.9%

4/1 David Setboun Joins BrainStorm as Executive Vice President and Chief Operating Officer -4.7%

11/14 Q3/2019 9/30/2019 EPS -0.250 ZacksConsensus -0.160 ActVsEst (0.090) - Miss -4.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day